Back to News
Market Impact: 0.7

Google’s (GOOGL) Antitrust Trial for Its Advertising Business Begins

GOOGLNWSA
Antitrust & CompetitionLegal & LitigationRegulation & LegislationTechnology & InnovationCompany FundamentalsAnalyst EstimatesAnalyst InsightsMedia & Entertainment

Google (GOOGL) has begun its antitrust trial, where the U.S. government is seeking to break up parts of its advertising business, specifically demanding the divestiture of its AdX ad exchange and the open-sourcing of its auction system. Regulators allege Google exploited its market dominance to create illegal monopolies in web advertising technology, forcing publishers to use its ad server and favoring its own advertisers. While Google argues the proposals are unworkable and offers policy changes, regulators are prepared to mandate the sale of its publisher ad server if competition does not improve within four years, posing a significant challenge to the company's core revenue streams.

Analysis

Google (GOOGL) is confronting a significant legal challenge as its antitrust trial commences, with the Department of Justice seeking the divestiture of its AdX ad exchange and the open-sourcing of its auction system. The government's case is bolstered by a prior ruling from Judge Leonie Brinkema, who found Google holds illegal monopolies in web advertising technology, and will feature testimony from publishers alleging the company unfairly tied its ad server to AdX to favor its own advertisers. While Google has countered that the proposed remedies are unworkable and has offered policy changes, regulators remain steadfast, suggesting a forced sale of Google's publisher ad server could follow if competition does not improve within four years. This substantial regulatory risk creates a notable disconnect with Wall Street's current sentiment; despite a "Strong Buy" consensus rating based on 28 Buys and nine Holds, the average analyst price target of $239.76 implies a 5.8% downside, indicating that either price targets are lagging or the market has not fully priced in the potential for a negative trial outcome.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo